Your browser doesn't support javascript.
loading
SARS-CoV-2 mucosal neutralising immunity after vaccination.
Carr, Edward J; Dowgier, Guilia; Greenwood, David; Herman, Lou S; Hobbs, Agnieszka; Ragno, Martina; Stevenson-Leggett, Phoebe; Gahir, Joshua; Townsley, Hermaleigh; Harvey, Ruth; Bailey, Chris; Fowler, Ashley S; Miah, Murad; Smith, Callie; Miranda, Mauro; Bawumia, Philip; Mears, Harriet V; Adams, Lorin; Hatipoglu, Emine; O'Reilly, Nicola; Warchal, Scott; Sawyer, Chelsea; Ambrose, Karen; Strange, Amy; Kelly, Gavin; Beale, Rupert; Papineni, Padmasayee; Corrah, Tumena; Gilson, Richard; Gamblin, Steve; Kassiotis, George; Libri, Vincenzo; Williams, Bryan; Swanton, Charles; Gandhi, Sonia; Bauer, David L V; Wall, Emma; Wu, Mary Y.
Affiliation
  • Carr EJ; UCL Department of Renal Medicine, Royal Free Hospital, Rowland Hill Street, London, UK; The Francis Crick Institute, London NW1 1AT, UK.
  • Dowgier G; COVID Surveillance Unit, London NW1 1AT, UK.
  • Greenwood D; The Francis Crick Institute, London NW1 1AT, UK.
  • Herman LS; COVID Surveillance Unit, London NW1 1AT, UK.
  • Hobbs A; COVID Surveillance Unit, London NW1 1AT, UK.
  • Ragno M; COVID Surveillance Unit, London NW1 1AT, UK.
  • Stevenson-Leggett P; COVID Surveillance Unit, London NW1 1AT, UK.
  • Gahir J; The Francis Crick Institute, London NW1 1AT, UK; National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre and NIHR UCLH Clinical Research Facility, London, UK.
  • Townsley H; The Francis Crick Institute, London NW1 1AT, UK.
  • Harvey R; Worldwide Influenza Centre, London NW1 1AT, UK.
  • Bailey C; The Francis Crick Institute, London NW1 1AT, UK.
  • Fowler AS; The Francis Crick Institute, London NW1 1AT, UK.
  • Miah M; The Francis Crick Institute, London NW1 1AT, UK.
  • Smith C; The Francis Crick Institute, London NW1 1AT, UK.
  • Miranda M; The Francis Crick Institute, London NW1 1AT, UK.
  • Bawumia P; The Francis Crick Institute, London NW1 1AT, UK.
  • Mears HV; The Francis Crick Institute, London NW1 1AT, UK.
  • Adams L; Worldwide Influenza Centre, London NW1 1AT, UK.
  • Hatipoglu E; The Francis Crick Institute, London NW1 1AT, UK; University College London, London, UK.
  • O'Reilly N; The Francis Crick Institute, London NW1 1AT, UK.
  • Warchal S; The Francis Crick Institute, London NW1 1AT, UK.
  • Sawyer C; The Francis Crick Institute, London NW1 1AT, UK.
  • Ambrose K; The Francis Crick Institute, London NW1 1AT, UK.
  • Strange A; The Francis Crick Institute, London NW1 1AT, UK.
  • Kelly G; The Francis Crick Institute, London NW1 1AT, UK.
  • Beale R; The Francis Crick Institute, London NW1 1AT, UK; The Francis Crick Institute, London NW1 1AT, UK; Genotype-to-Phenotype UK National Virology Consortium, London, UK.
  • Papineni P; London Northwest University Healthcare NHS Trust, London, UK.
  • Corrah T; London Northwest University Healthcare NHS Trust, London, UK.
  • Gilson R; Central and North West London NHS Foundation Trust, London, UK; University College London, London, UK.
  • Gamblin S; The Francis Crick Institute, London NW1 1AT, UK.
  • Kassiotis G; The Francis Crick Institute, London NW1 1AT, UK; Department of Infectious Disease, St Mary's Hospital, Imperial College London, London, UK.
  • Libri V; National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre and NIHR UCLH Clinical Research Facility, London, UK; University College London, London, UK.
  • Williams B; National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre and NIHR UCLH Clinical Research Facility, London, UK; University College London, London, UK.
  • Swanton C; The Francis Crick Institute, London NW1 1AT, UK; University College London, London, UK.
  • Gandhi S; The Francis Crick Institute, London NW1 1AT, UK; University College London, London, UK.
  • Bauer DLV; The Francis Crick Institute, London NW1 1AT, UK; Genotype-to-Phenotype UK National Virology Consortium, London, UK.
  • Wall E; The Francis Crick Institute, London NW1 1AT, UK; National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre and NIHR UCLH Clinical Research Facility, London, UK.
  • Wu MY; COVID Surveillance Unit, London NW1 1AT, UK; The Francis Crick Institute, London NW1 1AT, UK. Electronic address: mary.wu@crick.ac.uk.
Lancet Infect Dis ; 24(1): e4-e5, 2024 Jan.
Article in En | MEDLINE | ID: mdl-38070528
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Limits: Humans Language: En Journal: Lancet Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2024 Type: Article Affiliation country: United kingdom
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Limits: Humans Language: En Journal: Lancet Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2024 Type: Article Affiliation country: United kingdom